Stock Events

Stock Events

Profound Medical 

$6.89
13
+$0.09+1.32% Friday 20:00
+$0.00+0%Friday 20:00After hours

Statistics

Day High
6.96
Day Low
6.89
52W High
8.95
52W Low
3.76
Volume
1,777
Avg. Volume
-
Mkt Cap
251.76M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29OctExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.72
-0.57
-0.41
-0.26
Expected EPS
-0.3136164612
Actual EPS
N/A

Financials

-264.44%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
16.1MRevenue
-42.57MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PROF. It's not an investment recommendation.
Enbridge
3
ENB.TO
Toronto Dominion Bank
3
TD.TO
Apple
2
AAPL
Microsoft
2
MSFT.NEO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, overlapping with Profound Medical's minimally invasive approaches.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc manufactures and sells device-based medical therapies, including those for prostate health, competing in similar therapeutic areas.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation develops minimally invasive medical devices, competing in the interventional medicine space.
Globus Medical
GMED
Mkt Cap11.14B
Globus Medical, Inc. focuses on musculoskeletal solutions but also explores technologies that could compete in minimally invasive treatments.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation specializes in medical technologies across various fields, including surgical devices that could compete with Profound's offerings.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but is expanding into new technologies that could compete with minimally invasive treatments.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson engages in the development of medical devices, including surgical systems that could rival Profound Medical's technologies.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories offers a broad range of medical devices, potentially competing in the same healthcare segments as Profound Medical.

About

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Show more...
CEO
Arun Swarup Menawat
Employees
162
Country
Canada
ISIN
CA74319B5027

Listings

TO
CA
PRN.TO
XNAS
US
PROF
BOATS
BOATS
PROF.BOATS

0 Comments

Share your thoughts

FAQ

What is Profound Medical stock price today?▼
The current price of PROF is $6.89 USD — it has increased by +1.32% in the past 24 hours. Watch Profound Medical stock price performance more closely on the chart.
What is Profound Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Profound Medical stocks are traded under the ticker PROF.
Is Profound Medical stock price growing?▼
PROF stock has risen by +0.58% compared to the previous week, the month change is a -13.77% fall, over the last year Profound Medical has showed a +67.23% increase.
What is Profound Medical market cap?▼
Today Profound Medical has the market capitalization of 251.76M
When is the next Profound Medical earnings date?▼
Profound Medical is going to release the next earnings report on October 29, 2026.
What were Profound Medical earnings last quarter?▼
PROF earnings for the last quarter are -0.26 USD per share, whereas the estimation was -0.24 USD resulting in a -7.22% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Profound Medical revenue for the last year?▼
Profound Medical revenue for the last year amounts to 16.1M USD.
What is Profound Medical net income for the last year?▼
PROF net income for the last year is -42.57M USD.
How many employees does Profound Medical have?▼
As of September 05, 2026, the company has 162 employees.
In which sector is Profound Medical located?▼
Profound Medical operates in the Health & Wellness sector.
When did Profound Medical complete a stock split?▼
The last stock split for Profound Medical was on October 16, 2019 with a ratio of 1:10.
Where is Profound Medical headquartered?▼
Profound Medical is headquartered in MISSISSAUGA, Canada.